Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension-Reference-Cited by-同舟云学术

Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension

Published:2017-05-11 Issue:7 Volume:19 Page:695-701
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Johnson Wallace¹,White William B.²,Sica Domenic³,Bakris George L.⁴,Weber Michael A.⁵,Handley Alison⁶,Perez Alfonso⁷,Cao Charlie⁸,Kupfer Stuart⁷,Saunders Elijah B.¹

Affiliation:

1. University of Maryland School of Medicine Baltimore MD USA

2. Cardiology CenterUniversity of Connecticut School of Medicine Farmington CT USA

3. Virginia Commonwealth University Health System Richmond VA USA

4. University of Chicago Medicine Chicago IL USA

5. SUNY Downstate College of Medicine New York NY USA

6. Takeda Pharmaceuticals International Inc. Deerfield IL USA

7. Takeda Development Center Americas Inc. Deerfield IL USA

8. Takeda Pharmaceuticals America Inc

Funder

Takeda Development Center Americas, Inc.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.12993

Reference33 articles.

1. Systematic Review: Antihypertensive Drug Therapy in Black Patients

2. Difference in blood pressure response to ACE-Inhibitor monotherapy between black and white adults with arterial hypertension: a meta-analysis of 13 clinical trials

3. The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

4. Race-based therapeutics

5. Edarbi (azilsartan medoxomil) complete prescribing information.http://edarbyclorrx.com/efficacy/#edarbi. Accessed February 21 2017.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-04

2. Changing Concepts About Optimal Target Blood Pressure and the Therapeutic Advantages of Azilsartan for Achieving it;Kardiologiia;2024-04-30

3. Association between serum 25‐hydroxyvitamin D and the effects of Angiotensin II receptor blocker on renal function among African Americans: A post hoc analysis of a randomized placebo‐controlled trial;The Journal of Clinical Hypertension;2020-08-18

4. Efficacy and safety of different doses of azilsartan medoxomil in patients with hypertension;Medicine;2019-09

5. Angiotensin II receptor blocker attenuates stress pressor response in young adult African Americans;The Journal of Clinical Hypertension;2019-07-22